Amigula Incorporated -- The World's First Publicly Traded Medical Marijuana Company.

Business Editors

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--March 15, 2004

Announces Today that the Company Has Formulated a Plan to Have

Well-Known Hollywood Celebrities -- Entertainers --

Endorse the Company and the Company's Products

Amigula Incorporated (OTC:AMJL), the world's first publicly traded medical marijuana company, today announced that several Hollywood agents and management groups have been working with their clients at the bequest of Amigula Inc., negotiating contracts with "Super Stars" willing to endorse medical marijuana as a viable medicinal therapy for a variety of extreme illnesses, including multiple sclerosis, epilepsy, arthritis, glaucoma, AIDS, nausea - chemotherapy, anxiety and stress, as well as for several other dysfunctions.

"We approached several well-known talent agents and managers to request that they approach their talent and present our cause and opportunity to them. Some of the stars wished us well and declined at first, then called their agents back after thinking things over and said 'Let's talk,'" said Warren Eugene, president, Amigula Inc.

"We require a star who is well known and trusted by a geriatric and maturing population. We require someone to educate people with us. There is so much by way of misconception and myth surrounding marijuana; it needs a star to assist us in getting the message right. That message is a simple one -- that marijuana is an excellent alternative homeopic therapy for those truly suffering and requiring medications. We are an agricultural pharmaceutical company on a mission to do good for others.

"So that's when it hit me, what about stars who have excelled at fighting for others with illness. These stars are heroes to millions of people the world over.

"One star actually did a TV episode where she smoked marijuana. She is of the right age and high quality to endorse our company and products. We are pursuing her. There are several stars who would be naturals for us.

"Some have had to personally battle major illness; they had to go through treatment for illness and could empathize with millions of other people requiring therapeutic relief.

"There will be many stars, before too long, who will come to our side and join us in this important quest, of that I'm certain. It's still early; we just got started a few months ago. I'm confident that things will work out well for us. This is history in the making," said Eugene.

About Amigula Inc.

Amigula Inc. (www.Amigula.com) has recently completed the purchase of 51% of Medical Cannabis Inc. and has announced their plans to file as a reporting issuer. The company plans to list on a major exchange beginning with an application for a listing on the American Stock Exchange (AMEX) or Nasdaq, as well as several European exchanges. The company views the current prohibition of marijuana as similar to that of alcohol, beer and tobacco. Canada's marijuana crop alone is estimated at $4 billion to $7 billion. If a single company controlled it, it would be larger than Canada's oil and gas business and agricultural industries. On October 7, 2003, the Ontario Superior Court ruled that business and individuals be allowed to grow and supply medical marijuana, effectively relieving the Canadian government of its often criticized and fairly unsuccessful attempts. Health Canada "permitted persons" (exemptees) can now pay Amigula to grow marijuana for them. The ruling makes it easier for sick people to get marijuana by allowing them easier access -- more choice and fair prices. The company has a mandate to develop and improve the medical marijuana business worldwide and is on the acquisition and consolidation trail of other legal licensed marijuana operations with notable international brands.

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward- looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.